Replies to post #126638 on Biotech Values

[biomaven0]

marketed to Dermatologists and pathologists for "borderline lesions" these are acceptable numbers

I'd say these are "borderline" numbers. :)

Much better if they instead had high sensitivity and low specificity for this indication.

Peter